Profile for Cyprus Patent: 1123498
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Cyprus Patent: 1123498
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,195,168 | Jan 11, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 10,675,258 | Jan 11, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 11,554,102 | Jan 11, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 8,591,922 | Jan 11, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 8,901,173 | Jan 11, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| 9,132,107 | Jan 11, 2033 | Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
